December 2, 2025 · Form 4 insider transaction
Guyer William sold 19,360 shares of Corcept Therapeutics Incorporated at $80.05 per share, a transaction worth $1.55M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction.; Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $79.78 to $80.68 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.